Amendment: Decommissioning unique identifiers for UK medicinal exports

This regulation updates the rules for pharmaceutical wholesalers exporting medicines to the United Kingdom. It specifically addresses the 'decommissioning' process—the step where a unique identifier is deactivated in a database to prevent counterfeit drugs from entering the legal supply chain.

This change affects pharmaceutical wholesalers and distributors. It allows for a derogation, meaning a temporary exception, from standard decommissioning requirements to ensure the smooth flow of medicines to the UK market.